PHVS

31.4400.69%
SA

Stefan Abele

Chief Technology Operations Officer

Dr. Stefan Abele, Ph.D., is Chief Technology Operations Officer of Pharvaris N.V. from November 2023. In this role, he is be responsible for all chemistry, manufacturing and controls (CMC) activities, supply chain and program management as Pharvaris progresses into late-stage clinical development. Dr. Abele was Senior VP and Head of Chemical Development & Commercial Manufacturing of Idorsia Ltd until October 2023. Dr. Abele was VP and Head of Chemical Development & Commercial Manufacturing of Idorsia Ltd. Dr. Abele was employed at Idorsia Ltd from June 2017 to October 2023. Dr. Abele joins Pharvaris with more years of experience in process development, end-to-end Active Pharmaceutical Ingredients (API) supply chain, cross-functional CMC activities, GMP manufacturing, global vendor management and people leadership. Previously, Dr. Abele served as the Senior Vice President, Chemical Development and Commercial Manufacturing at Idorsia Pharmaceuticals, where he and his team were responsible for the API development and manufacturing of QUVIVIQ (daridorexant), PIVLAZ (clazosentan) and aprocitentan. Prior to Idorsia, Dr. Abele worked at Actelion Pharmaceuticals where he established and grew the fully integrated Chemistry Process R&D department. Earlier, he held positions of growing responsibility at Carbogen-Amcis, including as Head of Production and as a manager of teams in R&D and GMP manufacturing of APIs for global pharma companies. Dr. Abele has Ph.D. in Organic Chemistry from Eidgenössische Technische Hochschule Zürich. Dr. Abele attended Universität Konstanz with Diploma in Chemistry.

Positions